Pharmacokinetics and Interaction Profile of Topiramate: Review and Comparison with Other Newer Antiepileptic Drugs
Open Access
- 1 January 1997
- Vol. 38 (s1) , S18-S23
- https://doi.org/10.1111/j.1528-1157.1997.tb04512.x
Abstract
Summary: Standard antiepileptic drugs (AEDs) have a number of pharmacokinetic shortcomings, and AEDs with more favorable profiles would be preferred. The pharmacokinetics and interaction profile of the recently developed AED topiramate (TPM), is reviewed and compared with those of other newer AEDs including lamotrigine (LTG), gabapentin (GBP), vigabatrin (VGB), and oxcarbazepine (OCBZ). Although none of these agents meets all of the criteria of the “ideal” AED from the pharmacokinetic standpoint, a number of these drugs, including TPM, have desirable properties that distinguish them from the older AEDs and should contribute to their clinical utility.Keywords
This publication has 24 references indexed in Scilit:
- LamotrigineEpilepsia, 1995
- VigabatrinEpilepsia, 1995
- Neuropharmacology and Drug Interactions in Clinical PracticeEpilepsia, 1995
- Felbamate in the Treatment of Lennox‐Gastaut SyndromeEpilepsia, 1994
- LamotrigineDrugs, 1993
- Pharmacokinetic Optimisation of Anticonvulsant TherapyClinical Pharmacokinetics, 1992
- OxcarbazepineDrugs, 1992
- Pharmacokinetics of Antiepileptic DrugsSeminars in Neurology, 1990
- The metabolism of14C-oxcarbazepine in manXenobiotica, 1986
- Pharmacokinetics of 10-OH-carbazepine, the main metabolite of the antiepileptic oxcarbazepine, from serum and saliva concentrationsActa Neurologica Scandinavica, 1983